Literature DB >> 32702757

Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit.

Luca Spiezia1, Annalisa Boscolo2, Christelle Correale3, Nicolò Sella3, Elisa Pesenti3, Luca Beghetto3, Elena Campello4, Francesco Poletto1, Lorenzo Cerruti1, Marco Cola5, Alessandro De Cassai2, Laura Pasin2, Serra Eugenio2, Roberto Vettor4, Anna Maria Cattelan5, Paolo Simioni1, Paolo Navalesi2,3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32702757     DOI： 10.1055/s-0040-1714350

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  14 in total

1.  Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation.

Authors:  Francesco Poletto; Luca Spiezia; Chiara Simion; Elena Campello; Fabio Dalla Valle; Daniela Tormene; Giuseppe Camporese; Paolo Simioni
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

2.  The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.

Authors:  Adriana Albini; Giovanni Di Guardo; Douglas McClain Noonan; Michele Lombardo
Journal:  Intern Emerg Med       Date:  2020-05-19       Impact factor: 3.397

3.  Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.

Authors:  Artem Minalyan; Franklin L Thelmo; Vincent Chan; Stephanie Tzarnas; Faizan Ahmed
Journal:  J Med Case Rep       Date:  2021-03-02

4.  Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases.

Authors:  Connor M Bunch; Anthony V Thomas; John E Stillson; Laura Gillespie; Kevin P Lin; Jacob Speybroeck; Hau C Kwaan; Daniel H Fulkerson; Mahmud Zamlut; Rashid Khan; Mark M Walsh
Journal:  Am J Case Rep       Date:  2021-04-01

5.  Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A rotational thromboelastometry study.

Authors:  Federico Capone; Alberto Cipriani; Leonardo Molinari; Anna Poretto; Nicolò Sella; Annalisa Boscolo; Elena Campello; Alois Saller; Roberto Vettor; Paolo Navalesi; Anna Maria Cattelan; Paolo Simioni; Luca Spiezia
Journal:  Adv Med Sci       Date:  2021-12-11       Impact factor: 3.287

6.  Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.

Authors:  Mehmet Gökhan Gönenli; Zeynep Komesli; Said İncir; Özlem Yalçın; Olga Meltem Akay
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Two Consecutive Runs of Veno-Venous Extracorporeal Membrane Oxygenation in a Peripartum Patient with COVID-19 Acute Respiratory Distress Syndrome.

Authors:  Nicolò Sella; Tommaso Pettenuzzo; Michele Della Paolera; Giulio Andreatta; Annalisa Boscolo; Alessandro De Cassai; Luisa Muraro; Arianna Peralta; Paolo Persona; Enrico Petranzan; Francesco Zarantonello; Eugenio Serra; Paolo Navalesi
Journal:  Case Rep Crit Care       Date:  2021-07-09

Review 8.  Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.

Authors:  Vittorio Pavoni; Lara Gianesello; Maddalena Pazzi; Pietro Dattolo; Domenico Prisco
Journal:  J Clin Monit Comput       Date:  2021-07-15       Impact factor: 1.977

Review 9.  The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.

Authors:  Rajat Bhattacharyya; Prasad Iyer; Ghee Chee Phua; Jan Hau Lee
Journal:  Pulm Ther       Date:  2020-08-25

10.  Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables.

Authors:  Nicolò Sella; Francesco Zarantonello; Giulio Andreatta; Veronica Gagliardi; Annalisa Boscolo; Paolo Navalesi
Journal:  Crit Care       Date:  2020-09-01       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.